Skip to main content
Livermore
Livermore
ZHEN

Genmab A/S

GNMSF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001434265

No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesGMAB

Holders of 5% or more of GNMSF

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Genmab A/S, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of GNMSF
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A5.60%3.71M shares–Apr 23, 20251 filingApr 23, 2025SEC
Orbis Investment Management Ltd13G/A5.30%3.32M shares−0.20 ppfrom 5.50%Nov 14, 20254 filingsAug 14, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

5 Schedule 13D and 13G filings on Genmab A/S, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on GNMSF
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20261:14 PM ETOrbis Investment Management Ltdand 1 other13G/A5.30%3.32M shares−0.20 ppfrom 5.50%Jun 30, 2026SEC
May 15, 20261:05 PM ETOrbis Investment Management Ltdand 1 other13G/A5.50%3.55M shares−1.10 ppfrom 6.60%Mar 31, 2026SEC
Feb 17, 202612:07 PM ETOrbis Investment Management Ltdand 1 other13G/A6.60%4.23M shares+0.80 ppfrom 5.80%Dec 31, 2025SEC
Nov 14, 202512:26 PM ETOrbis Investment Management Ltdand 1 other13G5.80%3.73M sharesNewSep 30, 2025SEC
Apr 23, 20257:39 PM ETBlackRock, Inc.13G/A5.60%3.71M shares–Mar 31, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Genmab A/S shares.

No Form 144 notices for Genmab A/S are on file.